PETALUMA, Calif. – Oculus Innovative Sciences, Inc. today announced that its Microcyn® Wound Care OTC, a non-irritating pH-balanced wound cleanser, is now available over-the-counter in the United States. Microcyn Wound Care OTC, which has been cleared by the FDA for moistening absorbent wound dressings and cleaning minor cuts, minor burns, superficial abrasions and minor irritations of the skin, is safe to use around the nose, mouth and eyes. Additionally, it is ready to use with no mixing, dilution or rinsing required and can be used directly on the wound or in combination with gauze, sponges or other absorbent wound dressings.
“There has been increasing demand from U.S. consumers for over-the-counter access to the Microcyn technology,” said Hoji Alimi, CEO and founder of Oculus. “Based upon our successful test marketing and positive feedback from U.S. physicians, including those associated with our ongoing product launch into the U.S. podiatry market, we believe Microcyn Wound Care OTC will provide consumers with an exciting and demonstrative wound care alternative.”
Upon successful completion of the OTC introduction, the company plans to explore additional distribution channels via partners and retailers.
Microcyn Wound Care OTC can be ordered for $20 plus shipping, handling and tax for an eight-ounce bottle by phone at (800) 759-9305 and at www.oculusis.com/us/otc.
Source: Oculus Innovative Sciences
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.